• MK-4827 (Niraparib): PARP Inhibition Research

  2026-09-23

  MK-4827, also known as Niraparib, is a research inhibitor of PARP-1 and PARP-2 that blocks a DNA damage repair pathway. Its reported biochemical potency and BRCA-mutant cell findings support cancer research, while a hepatocellular carcinoma study provides a separate, context-specific rationale for studying spliceosome regulation alongside PARP inhibition.

• Gepotidacin Mechanism at S. aureus Gyrase

  2026-09-23

  The reference study defines how gepotidacin inhibits Staphylococcus aureus gyrase through a mechanism distinct from that of fluoroquinolones. Biochemical assays and high-resolution structures show potent inhibition, persistent gyrase–DNA complexes, and predominantly single-stranded DNA cleavage, providing a mechanistic framework for studying antibacterial agents that can retain activity against fluoroquinolone-resistant bacteria.

• EPZ5676: A Selective DOT1L Inhibitor Workflow

  2026-09-22

  EPZ5676 enables a tightly controlled path from SAM-pocket inhibition to H3K79 methylation loss and leukemia-cell response. This workflow combines biochemical validation, MLL-rearranged models, orthogonal target-engagement assays, and immune-signature controls to improve interpretation and reproducibility.

• Tofacitinib Citrate: Immune Assay Workflows

  2026-09-22

  Build concentration-aware workflows with Tofacitinib citrate for JAK-STAT signaling, lymphocyte proliferation inhibition, and T-cell differentiation studies. A comparative endothelial-cell framework helps researchers separate useful anti-inflammatory activity from high-dose vascular stress signals.

• GS-4997 and Tubulointerstitial Injury in Lupus Nephritis

  2026-09-21

  The reference study identifies ASK1 signaling as a pharmacologically tractable driver of tubulointerstitial injury in lupus nephritis. In female MRL/lpr mice and LPS-stimulated HK-2 cells, GS-4997 reduced inflammation, fibrosis, tubular damage, and downstream p38/JNK activation, supporting further mechanistic investigation rather than establishing a clinical treatment.

• IL-1β Tetrapeptide Controls Inflammatory Caspases

  2026-09-21

  The reference preprint identifies the P4–P1 tetrapeptide adjacent to the canonical IL-1β cleavage site as a determinant of recruitment and productive processing by inflammatory caspases. It also reports direct IL-18 cleavage by human caspases-4/-5 and an apparently inactive IL-1β fragment generated by non-canonical caspases, refining how inflammasome proteases should be interpreted in cytokine and pyroptosis studies.

• Phosphoproteomic Adaptation to Cabozantinib in RCC

  2026-09-20

  This study distinguishes acute from chronic Cabozantinib exposure in renal cell carcinoma by integrating quantitative phosphoproteomics with migration and invasion assays. Its main contribution is a timescale-aware model in which broad cytostatic phosphorylation changes evolve into selective adhesion-, stress-, and MAPK/AP-1-associated remodeling while MET activation-loop phosphorylation remains suppressed.

• ATRA Sensitizes Ovarian Cancer to Niraparib

  2026-09-19

  The reference study shows that all-trans retinoic acid can reduce cisplatin-induced resistance to niraparib in epithelial ovarian cancer models. Its treatment-sequence findings connect retinoid signaling with suppression of an ALDH1A1–NAMPT–PARP1–CHK1 and NAD+-associated resistance state, supporting a maintenance strategy that combines ATRA with PARP inhibition.

• Silymarin Workflows for Translational Research

  2026-09-19

  Silymarin, a chemically diverse milk thistle extract, gives researchers a practical probe for oxidative injury, tumor biology, metabolic dysfunction, and selected antiviral target assays. This guide turns its solubility, mixture composition, and redox activity into controlled workflows with dose-selection, orthogonal validation, and troubleshooting strategies.

• Alpha-Ketoglutarate at the Tumor–Immune Interface

  2026-09-18

  A translational analysis of how α-KGA connects mitochondrial metabolism, PDHA1 succinylation, macrophage antigen presentation, and chemotherapy response in cholangiocarcinoma research.

• CSBTA Pharmacokinetics in MASH Mice

  2026-09-17

  This study shows that HFHCD-induced MASH changes the systemic exposure, hepatic distribution, and hepatocyte accumulation of key Corydalis saxicola Bunting total alkaloids. By combining UHPLC-MS/MS, transporter and microsomal assays, and analyses of CYP450s and PXR-related regulation, the work provides a disease-state framework for interpreting pharmacokinetic variability and optimizing future MASH dosing studies.

• GCRV Entry and Clathrin-Mediated Endocytosis

  2026-09-17

  Wang et al. used pharmacological inhibitors, transmission electron microscopy, and real-time qPCR to show that genotype III grass carp reovirus enters CIK cells through a dynamin-dependent, acidification-sensitive clathrin pathway. The study also provides an important negative control for IPA-3: under the tested conditions, Pak1-directed inhibition did not measurably block GCRV entry or infection.

• Fluconazole for Reproducible Fungal Assays

  2026-09-16

  This scenario-driven guide explains how Fluconazole, SKU B2094, can support controlled fungal viability, susceptibility, and resistance experiments. It connects mechanism, solvent handling, dose selection, storage, and interpretation to practical laboratory decisions.

• JC-1 Mitochondrial Membrane Potential Assay Kit

  2026-09-16

  Build a ratiometric mitochondrial membrane potential assay around JC-1, CCCP controls, and matched treatment conditions. This practical guide connects mitochondrial depolarization measurements with apoptosis studies of hypoxia-activated cancer therapeutics while emphasizing optimization, controls, and interpretation limits.

• MK-4827: Reframing PARP Inhibition for Translation

  2026-09-15

  A translational perspective on MK-4827 (Niraparib), connecting PARP-1/-2 inhibition, BRCA-associated synthetic lethality, and hyperthermia-induced BRCA2 loss to better experimental design and combination strategy.

8546 records 1/570 page Next 12345 下5页 Last page